MARSHALL WACE, LLP

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 1318757 LONDON, X0

Position in PMVP

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$430,956

-$107,319 QoQ

Shares Held

321,610

-25.9% QoQ

Ownership

0.602%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#20

of 64 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. PMVP ranks #224 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$430,956	321,610	-25.9%	Shares	Other	2026-08-13
2026-03-31	$538,275	434,093	-6.7%	Shares	Other	2026-05-15
2025-12-31	$581,357	465,086	-24.1%	Shares	Other	2026-02-13
2025-09-30	$857,676	612,626	+5462.2%	Shares	Other	2025-11-13
2024-12-31	$16,631	11,014	-82.1%	Shares	Other	2025-02-13
2024-09-30	$91,919	61,691	+378.2%	Shares	Other	2024-11-14
2024-06-30	$20,898	12,900	-90.2%	Shares	Other	2024-08-14
2024-03-31	$224,136	131,845	+127.1%	Shares	Other	2024-05-15
2023-09-30	$356,500	58,062	+74.8%	Shares	Other	2023-11-14
2023-03-31	$158,483	33,225	-49.8%	Shares	Other	2023-05-15
2022-12-31	$576,000	66,207	+46.5%	Shares	Other	2023-02-14
2022-09-30	$537,963	45,207	+255.5%	Shares	Other	2022-11-14
2021-09-30	$378,936	12,716	-21.5%	Shares	Sole	2021-11-15
2020-12-31	$996,031	16,193	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.